INTRODUCTION
Plants produce a wide variety of secondary metabolites which provide characteristic pigment, odour and flavour characteristics. In addition, these compounds may also provide the plants with protection against microbial challenge.
1 Traditional plant derived medicines have been used for thousands of years in most parts of the world and with the increase in microbial antibiotic resistance, their use in fighting bacterial pathogens is becoming the focus of intense study. 2, 3 Whilst much of the research into traditional medicinal plant use has focused on Asian, 4 African 5 and South American 6 plants, the therapeutic potential of the flora of Australia has also been recognised for thousands of years. The first Australians had well developed ethnopharmacological systems and understood the therapeutic properties of a wide variety of aromatic Australian plants. 7 Despite this, relatively few studies have rigorously examined the antibacterial activity of Australian native plants. However, recently there has been increased study in this field. The healing properties of Australian plants of the family Myrtaceae have been understood by Australian Aborigines for many thousands of years. The genuses Leptospermum and Melaleuca are particularly prevalent in traditional Aboriginal healing systems. 7 More recently, Sir Joseph Banks (the botanist aboard Captain James Cook's voyage of the Endeavour) coined the phrase 'tea-tree' for the endemic Australian plant Melaleuca alternifolia due to similarities in use with Camellia sinensis, and some of its perceived therapeutic properties. 7 However, this common name creates some taxonomic confusion, with several Leptospermum and Kunzea species also collectively known as 'tea-tree' . Nowadays, a thriving trade exists, with 'tea tree' essential oils marketed globally as an antiseptic. The bacterial growth inhibitory properties of many genera within the family Myrtaceae have been documented. In particular, Callistemon spp., 8 Eugenia spp., 7 Kunzea spp. 7, 9 Leptospermum spp. 7, 10, 11 and Syzygium spp. [12] [13] [14] have been reported to inhibit the growth of a wide panel of bacteria, including many medicinally important pathogens. It is noteworthy that many of these studies have screened essential oils for antibacterial activity and the growth inhibitory properties of several Myrtaceae extracts are yet to be rigorously examined. Leptospermum longifolium (C.T. White & W.D. Francis) S.T. Blake ( Figure 1a) and Leptospermum petersonii Bailey (Figure 1b ) are large shrubs/small trees which are native to sclerophyll forests and subtropical rainforest areas of eastern Australia. Melaleuca alternifolia (Maiden & Betche) Cheel (commonly known as narrow leaved paperbark, narrow leaved tea-tree; Figure 1c ) is a related species which has a similar but limited occurrence in eastern Australian subtropical sclerophyll forests, particularly besides streams and in swampy areas. 1 The leaves of all 3 species are distilled commercially to produce essential oils rich in geraniol (Figure 1d Most studies into the antibacterial potential of the family Myrtaceae focus on the essential oil of the leaves. Melaleuca species, the levels and composition of the essential oil terpenoid components receives the most interest. In particular, the monoterpenoid compositions of several species have been extensively reported. 7 Leptospermum spp. essential oils contain especially high levels of citral, which comprises a mixture of geranial (β-citral; Figure 1d ) and neral (α-citral; Figure 1e ). 7, 15, 16 Both neral and geranial have been previously reported to have potent antibacterial activity against a variety of bacteria. [17] [18] [19] Similarly, a high composition of other monoterpenoids in various Myrtaceae essential oils has been reported, with citronellal (Figure 1f) , pinene (Figure 1g ), sabinene (Figure 1h ), α-terpinene (Figure 1i ), limonene ( Figure 1j ) and 1,8-cineole (Figure 1k ) often reported as major components. The antiseptic properties of these compounds is well established, with potent bacteriostatic and bactericidal activities reported. 22 Most of the studies reporting antibacterial properties for Leptospermum spp. and Melaleuca spp. have examined essential oils. However, the use of essential oils for the testing of antimicrobial activity can be problematic. The relative insolubility of many of the oil components retards their diffusion through agar gels in agar dilution or disc diffusion studies. Many studies have utilised solubilising agents (e.g. Tween 80) to aid oil component diffusion, resulting in variable results. 20, 21 Solubilising agents appear to increase the susceptibility of some bacteria to antimicrobial agents, decrease the susceptibility of others, whilst having no effect on yet other bacteria. The current study was undertaken to examine 3 taxonomically related Myrtaceae spp. (L. longifolium, L. petersonii and M. alternifolia) for growth inhibitory properties against a panel of pathogenic bacteria. 
MATERIALS AND METHODS

Plant collection and extraction
Qualitative phytochemical studies
Phytochemical analysis of the L. longifolium, L. petersonii and M. alternifolia leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by previously described assays. [23] [24] Antibacterial screening Test microorganisms 
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay. [25] [26] [27] Briefly, 100 µL of each bacterial culture was grown in 10 mL of fresh nutrient broth until they reached a count of ~10 8 cells/mL. A volume of 100 µL of the bacterial suspension was spread onto nutrient agar plates and extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of the plant extracts, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2 h before incubation at 30°C for 24 h. The diameters of the inhibition zones were measured to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10 µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10 µL of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of each extract against susceptible bacteria was determined as previously described. 28, 29 Briefly, the plant extracts were diluted in deionised water and tested across a range of concentrations. Discs were infused with 10 µL of the test dilutions, allowed to dry and placed onto inoculated plates. The assay was completed as outlined above and graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to determine the MIC values of each extract.
Bacterial growth time course assay
Bacterial growth time course studies were performed as previously described. 30 Briefly, 3 mL of the and A. hydrophilia, C. freundi and P. mirabilis bacterial cultures in nutrient broth were added individually to 27 mL nutrient broth containing 3 mL of 10 mg/mL methanolic plant extract to give a final concentration of 1000 µg/mL in the assay. The tubes were incubated at 30 o C with gentle shaking. The optical density was measured hourly at 550 nm for a 6 h incubation period. Control tubes were incubated under the same conditions but without the extract. All assays were performed in triplicate.
Toxicity screening Reference toxin for toxicity screening
Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 4 mg/mL solution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [31] [32] [33] Briefly, 400 µL of seawater containing approximately 54 (mean 54.2, n=75, SD 11.5) A. franciscana nauplii were added to wells of a 48 well plate and immediately used for bioassay. A volume of 400 µL of diluted plant extracts or the reference toxin were transferred to the wells and incubated at 25 ± 1 o C under artificial light (1000 Lux). A 400 µL seawater negative control was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was detected within 10 seconds. After 24 h, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was determined using probit analysis.
Statistical analysis
Data are expressed as the mean ± SEM of at least three independent experiments. One way ANOVA was used to calculate statistical significance between control and treated groups with a P value < 0.01 considered to be statistically significant.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1 g of L. longifolium, L. petersonnii and M. alternifolia leaves with methanol yielded dried extracts ranging from 93 mg (methanolic M. alternifolia extract) to 130 mg (methanolic L. longifolium extract) ( Table 1 ). The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO), resulting in the extract concentrations shown in Table 1 . Qualitative phytochemical studies showed that all extracts contained similar classes of phytochemicals. All had high levels of phenolics and tannins. Generally, all extracts also contained moderate levels of flavonoids and moderate to high levels of saponins. Low to moderate levels of triterpenoids, phytosterols and alkaloids were also present in all extracts. The L. longifolium, L. petersonnii and M. alternifolia extracts were devoid of all other classes of phytochemicals.
Antimicrobial activity
To determine the growth inhibitory activity of the L. longifolium, L. petersonii and M. alternifolia extracts against the panel of pathogenic bacteria, aliquots (10 µL) of each extract were screened in the disc diffusion assay. All extracts inhibited a broad spectrum of the gram negative bacterial species (Figure 2) . Indeed, all extracts inhibited the growth of 5 of the 10 gram negative bacteria screened (50%). The methanolic L. longifolium extract was a potent growth inhibitor against most bacterial species (as assessed by the sizes of the zones of inhibition), with zones of inhibition >10 mm against A. hydrophilia, C. freundi and P. mirabilis. 
aureus).
Noteably, the Leptospermum spp. extracts were substantially more potent inhibitors of gram positive bacterial growth than was the M. alternifolia extract. The antimicrobial efficacy was further quantified by determining the MIC values for each extract against the microbial species which were determined to be susceptible. All extracts were potent growth inhibitors of several bacterial species (as judged by MIC; Table 2 ). P. mirabilis was highly susceptible to all of the extracts, with MIC values generally <500 µg/mL (<5 µg infused into the disc). As P. mirabilis infection is a common cause of urinary tract infections and has also been identified as a trigger of rheumatoid arthritis, 38, 39 the L. longifolium, L. petersonii and M. alternifolia leaf extracts have potential for the prevention and treatment of these diseases in genetically susceptible individuals. The L. longifolium and L. petersonii extracts, but not the M. alternifolia extract, were also potent K. pneumoniae growth inhibitors (MIC's of 320 and 687 µg/mL for the L. longifolium and L. petersonii extracts respectively). As K. pneumoniae can trigger ankylosing spondylitis in genetically susceptible individuals, 40, 41 these extracts may also be useful in the prevention and treatment of this disease. Furthermore, all extracts were moderate inhibitors of S. pyogenes growth, with MIC values 1000-1500 µg/mL. S. pyogenes may cause a myriad of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, depending on which tissue it infects. 42, 43 Thus, the methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts may also be useful in the prevention and treatment of these diseases. L. longifolium, L. petersonii and M. alternifolia extracts were also good inhibitors of A. hydrophilia, with MICs of 147, 279 and 705 µg/mL respectively. The L. longifolium and L. petersonii extracts, but not the M. alternifolia extract, were also potent inhibitors of C. freundi, B. cereus, S. aureus and S. epidermidis growth, with MIC values substantially <1000 µg/mL. The M. alternifolia extract also inhibited the growth of these bacteria, albeit with higher MICs indicative of only moderate growth inhibition.
Bacterial growth time course assay
The antibacterial activity of the L. longifolium, L. petersonii and M. alternifolia extracts was further investigated in the reference bacterial strains by bacterial growth time course assays in the presence and absence of the extract. As A. hydrophilia, C. freundi, and P. mirabilis were the most susceptible to the L. longifolium, L. petersonii and M. alternifolia extracts, these species were selected for growth time course studies. The starting concentration of the extract used in these assays was 1000 µg/mL. All extracts significantly inhibited A. hydrophilia (Figure 4a ), C. freundi ( Figure 4b ) and P. mirabilis (Figure 4c ) growth within 1 h, indicating a rapid antimicrobial action. Furthermore, growth inhibition of all bacterial species by the L. longifolium, L. petersonii and M. alternifolia extracts was still significantly inhibited by the end of the 6 h time course study. This may indicate that these extracts have bactericidal activity against these bacteria at the doses tested.
Quantification of toxicity
The toxicity of the L. longifolium, L. petersonii and M. alternifolia extracts was initially tested in the Artemia franciscana nauplii bioassay at a concentration of 2000 µg/mL ( Figure 5 ). All extracts induced low levels of mortality at 24 and 48 h, similar to the % mortality seen for the seawater control. As none of the extracts induced >50% mortality, all were deemed to be nontoxic. Extracts with an LC 50 of greater than 1000 µg/mL towards Artemia nauplii have previously been defined as being nontoxic. 32 In contrast, the potassium dichromate positive controls induced mortality within 4 h (results not shown), with 100% mortality induction seen by 24 h.
DISCUSSION
Plant derived remedies are becoming increasingly sought after in the treatment of a myriad of diseases and disorders due both to their perception of greater safety than synthetic drugs, and the failure of current drug regimens to effectively treat many diseases. Our study examined the ability of methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts to inhibit the growth of a panel of medicinally important bacterial pathogens, and on their toxicity. The gram positive and gram negative bacteria tested in this study were susceptible to all of Pharmacognosy Communications, Vol 6, Issue 4, Oct-Dec, 2016 the extracts, although a greater susceptibility was noted for gram positive bacterial species. Many previous studies with other plant species have also reported a greater susceptibility of gram positive bacteria towards solvent extracts for South American, 34 African 35 and Australian plant extracts. 36, 37 The L. longifolium, L. petersonii and M. alternifolia leaf extracts were particularly potent inhibitors of P. mirabilis (MIC values <500 µg/mL). As P. mirabilis infection is a common cause of urinary tract infections and has also been identified as a trigger of rheumatoid arthritis, 38,39 the L. longifolium, L. petersonii and M. alternifolia leaf extracts have potential for the prevention of these diseases in genetically susceptible individuals. The L. longifolium and L. petersonii extracts were also potent K. pneumoniae growth inhibitors. As K. pneumoniae can trigger ankylosing spondylitis in genetically susceptible individuals 40, 41 this extract may also be useful in the prevention and treatment of this autoimmune disease. Furthermore, all extracts were moderate inhibitors of S. pyogenes growth with MIC values 1000-1500 µg/mL. S. pyogenes may cause a myriad of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, depending on which tissue it infects. 42, 43 Thus, the methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts may also be useful in the prevention and treatment of these diseases. Aside from inhibition of the growth of the bacterial triggers of the autoimmune disease discussed above, the L. longifolium, L. petersonii and M. alternifolia leaf extracts were also moderate to good inhibitors of several other bacterial pathogens. All extracts inhibited A. faecalis, A. hydrophilia, C. freundi and B. cereus growth, with MICs generally <1000 µg/mL. Thus, these extracts have potential in the treatment diseases caused by these pathogens (e.g. food poisoning, diarrhoea and dysentery). The L. longifolium and L. petersonii extracts were also good inhibitors of S. aureus and S. epidermidis growth (MICs 400-1000 µg/mL). The M. alternifolia extract was a moderate inhibitor of the growth of these bacteria, with MICs <3000 µg/mL. As both of these bacteria are skin disease pathogens, these extracts also may have applications as topical treatments of these diseases. Whilst an investigation of the phytochemistry of the methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts was beyond the scope of our study, previous studies have reported high terpenoid contents for essential oils of these species. 7, 15 Similarly, other plants of the family Myrtaceae are also well known for their high terpenoid contents. 7 Monoterpenes have been reported to exert a wide variety of biological effects including antibacterial, antifungal, anti-inflammatory and antitumour activities 22 and therefore may contribute to the bacterial growth inhibitory activity of the L. longifolium, L. petersonii and M. alternifolia extracts reported in our study. A wide variety of monoterpenoids including camphor, carvone, cineole, borneol, menthone, pinene, terpinene, as well as their derivatives, inhibit the growth of an extensive panel of pathogenic and food spoilage bacteria. 44 Interestingly, several of these monoterpenoids have also been reported to suppress NF-κB signaling (the major regulator of inflammatory diseases). [45] [46] [47] [48] This may be particularly relevant for the extracts which inhibited P. mirabilis (a bacterial trigger of rheumatoid arthritis) 38, 39 and K. pneumoniae (a trigger of ankylosing spondylitis). 40, 41 The terpene components in these extracts may therefore have a pleuripotent mechanism in blocking the autoimmune inflammatory diseases and relieving its symptoms by acting on both the initiator and downstream inflammatory stages of the disease. Further phytochemical evaluation studies and bioactivity driven isolation of active components is required to further evaluate the mechanism(s) of bacterial growth inhibition. Another commonality between the inhibitory methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts was that all contained high levels of tannins (Table 1) . Many studies have reported potent growth inhibitory activities for a number of tannin compounds. Gallotannins have been reported to inhibit the growth of a broad spectrum of bacterial species 49 through a variety of mechanisms including binding cell surface molecules including lipotoichoic acid and proline-rich cell surface proteins, 50, 51 and by inhibiting glucosyltransferase enzymes.
52
Elligitannins are also highly potent inhibitors of bacterial growth, with MIC values as low as 62.5 µg/mL. 49, 51 Ellagitannins have also been reported to function via several antibiotic mechanisms including interaction with cytoplasmic oxidoreductases and by disrupting bacterial cell walls. 49, 51 Thus, it is likely that multiple compounds within the L. longifolium, L. petersonii and M. alternifolia leaf extracts may contribute to the inhibition of bacterial growth. The findings reported here also demonstrate that the L. longifolium, L. petersonii and M. alternifolia leaf extracts were nontoxic towards Artemia franciscana nauplii, with LC 50 values substantially > 1000 µg/mL. Extracts with LC 50 values > 1000 µg/mL towards Artemia nauplii are defined as being nontoxic. 32 Whilst our preliminary toxicity studies indicate that these extracts may be safe for therapeutic use, studies using human cell lines are required to further evaluate the safety of these extracts. Furthermore, whilst these studies have demonstrated the potential of the L. longifolium, L. petersonii and M. alternifolia leaf extracts in the development of future antibiotic chemotherapeutics for the prevention and treatment of urinary tract infections, autoimmune diseases (particularly rheumatoid arthritis and ankylosing spondylitis) and some skin diseases, more work is required to isolate the inhibitory components and determine the mechanism(s) of inhibition.
CONCLUSION
The results of this study demonstrate the potential of the L. longifolium, L. petersonii and M. alternifolia leaf extracts as inhibitors of pathogenic bacteria growth. Furthermore, their lack of toxicity indicates than they may be safe for internal as well as topical treatment in the doses tested. Further studies aimed at the purification and identification of bioactive components are needed to examine the mechanisms of action of these agents. The lethality of the aqueous and methanolic L. longifolium, L. petersonii and M. alternifolia leaf extracts (2000 µg/mL), potassium dichromate (1000 µg/mL) and a seawater control. Blue bars represent the % mortality following 24 h exposure to the extract/toxin. Green bars represent the % mortality following 48 h exposure to the extract/toxin. NC=negative (seawater) control; PC=positive control (1000 µg/mL potassium dichromate). All bioassays were performed in at least triplicate and are expressed as mean ± SEM.
